EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Programmable Lipid Functionalization of Nucleic Acid Nanoparticles Modulates Liver Cell-Type Targeting

Hyun Min Kim, Marjan Omer, Grant A Knappe iD, Patrick McMullen iD, Duy An Le, Ashwin Pasupathy, Daniel G Anderson iD, Mark Bathe iD

ACS Applied Materials & Interfaces · 2026

DOI: 10.1021/acsami.5c24581 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Applied Materials & Interfaces, 2026. Verfasst von Hyun Min Kim und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, United States. Hauptthemen laut MEDLINE: Nanoparticles, RNA, Small Interfering, Lipids, Liver. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Institute of Environmental Health Sciences, National Science Foundation Graduate Research Fellowship Program, Division of Cancer Prevention, National Cancer Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NanoparticlesRNA, Small InterferingLipidsLiverNucleic AcidsHumansHep G2 CellsReceptors, LDLAsialoglycoprotein ReceptorDNA NanostructuresHepatocytesEndocytosis

Stichwörter der Autor:innen

DNA origamibiomolecular coronadrug deliverymultivalencynanoparticlesnucleic acid therapeutics

Substanzen

RNA, Small InterferingReceptors, LDLAsialoglycoprotein ReceptorLipidsNucleic Acids

Autor:innen und Institutionen

  • Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, United States.
  • Department of Biomedicine, Aarhus University, 8000 Aarhus C, Denmark.
  • Department of Chemical Engineering, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, United States.
  • David H Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, United States.
  • Department of Anesthesiology, Boston Children's Hospital, Boston, Massachusetts 02115, United States.
  • Harvard and MIT Division of Health Science and Technology, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, United States.

ORCID-Profile: Grant A Knappe, Patrick McMullen, Daniel G Anderson, Mark Bathe

Förderung

  • National Institute of Environmental Health Sciences
  • National Science Foundation Graduate Research Fellowship Program
  • Division of Cancer Prevention, National Cancer Institute
  • Novo Nordisk
  • Army Research Office
  • National Institutes of Health

Zitieren

APA

Kim, H. M., Omer, M., Knappe, G. A., McMullen, P., Le, D. A., Pasupathy, A., Anderson, D. G., & Bathe, M. (2026). Programmable Lipid Functionalization of Nucleic Acid Nanoparticles Modulates Liver Cell-Type Targeting. ACS Applied Materials & Interfaces. https://doi.org/10.1021/acsami.5c24581

Vancouver

Kim HM, Omer M, Knappe GA, McMullen P, Le DA, Pasupathy A, et al. Programmable Lipid Functionalization of Nucleic Acid Nanoparticles Modulates Liver Cell-Type Targeting. ACS Applied Materials & Interfaces. 2026. doi:10.1021/acsami.5c24581

BibTeX
@article{Kim2026,
  author = {Kim, Hyun Min and Omer, Marjan and Knappe, Grant A and McMullen, Patrick and Le, Duy An and Pasupathy, Ashwin and Anderson, Daniel G and Bathe, Mark},
  title = {Programmable Lipid Functionalization of Nucleic Acid Nanoparticles Modulates Liver Cell-Type Targeting},
  journal = {ACS Applied Materials & Interfaces},
  year = {2026},
  doi = {10.1021/acsami.5c24581}
}
Kostenlos starten →